Patheon provides contract development and manufacturing organization (CDMO) services for drug development, clinical trial logistics, and commercial manufacturing.

Patheon

Domain Not Resolving

HSTS

DNSSEC

reCAPTCHA

IPv6

Cloudflare Hosting

Cloudflare

Amazon S3

Microsoft

Amazon Route 53

Executive Vice President and Chief Financial Officer

Stuart Grant

Vice President Global Sales & Marketing Operations

Alex Graham

VP, Business Services

David Hamby

Vice President of North American Supply Chain

Jason Mieding

VP Business Management

John Foy

Vice President of Human Resources and Public Relations

Miriam Swiler

SVP Global Engineering and Capacity Planning

Ray Guidotti

VP Human Resources

Rey Rodriguez

Director of Analytical and Formulation Sciences

Amit Katiyar

Senior Director, Engineering

Brian Mccourt

Daniel Agroskin

Manja Bouman

President, Biologics

John Ward

Vice President of Engineering

Ijeoma Ikechukwu

Senior Scientist, Downstream Process Development

Pharmaceutical Companies With More Than 1000 Employees

Pharmaceutical Companies With More Than $50M in Revenue

North Carolina Acquired Companies With More Than $100M in Revenue

Manufacturing Companies With More Than $50M in Revenue (Top 10K)

Patheon Inc. provides commercial manufacturing and pharmaceutical development services to the pharmaceutical and biotechnology industries worldwide. Its commercial manufacturing activities relate primarily to prescription and over-the-counter products in solid, semi-solid, liquid, and sterile dosage forms. The company also provides a range of specialized pharmaceutical development capability, including high-potency, sterile, lyophilization, and controlled-release. Patheon delivers products to approximately 120 countries and offers an array of services, including manufacturing, logistics, and packaging of conventional dosage forms, sterile dosage forms, and specialized products. Its contract pharmaceutical development services include pre-formulation, formulation and development of dosage forms; development of analytical methods; manufacture to customer specifications of proposed new drug products during the regulatory drug approval process, including the manufacture of pilot batches; clinical packaging; and scale-up and technology transfer services to validate commercial-scale drug manufacturing processes. The company was founded in 1974 and is based in Mississauga, Canada.

Raleigh

North Carolina

United States

North America

Aurobindo eyes Indian bio-CDMO dominance - BioProcess ...

Companies that had their IPO in 2016

AGC and eXmoor CDMO facilities now open - BioProcess ...

Liquisoft capsules

Oxcia contracts Patheon for manufacturing and further strengthens the organization

Liquid dosage forms of sodium naproxen

Abuse-deterrent compositions

Thermo Fisher Scientific Declares Quarterly Dividend

Single-Use Equipment for Biopharmaceutical Market Analysis as per the Latest COVID-19 Impact

Cantargia Signs Agreement With Patheon Biologics B.V. for Production of Antibody CAN04

Provides integrated services for drug development and manufacturing, including both small and large molecules, from preclinical stages to commercialization.

Offers comprehensive services for clinical trials, including strategy, management, packaging, labeling, storage, and distribution.

Supports the final steps of drug development and manufacturing journey, ensuring efficient commercialization of medicines.

Specializes in the development and manufacturing of advanced therapies, including viral vectors, cell therapy, and mRNA.

Focuses on the development and manufacturing of biologics, employing technologies like fed-batch, perfusion, and XD for scalable processes.

Provides services for the development and manufacturing of small molecule drugs, addressing challenges like solubility and bioavailability.

Finland

Europe

Canada

Kyrgyzstan

Asia

Philippines

HTML5

Oracle Eloqua

Microsoft Outlook

jQuery

Amazon EC2

DigiCert

Office 365

Google Drive

Google Maps API

Modernizr

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 28, 2024 4:14 PM	48f6e91a
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 28, 2024 4:14 PM	a91e4323
crunchbase trigger	general	Nov 25, 2024 9:09 AM	78825590
crunchbase profile	general	Nov 25, 2024 10:51 AM	53eabf58
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 4:18 PM	8300bfe0
peers	general	Sep 28, 2024 4:14 PM	4cb28315
news basic	general	Sep 28, 2024 4:14 PM	ac60db0f
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:PATHEON

Patheon